Metabolomics Approach Reveals Integrated Metabolic Network Associated with Serotonin Deficiency

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Weng, Rui ^a   Shen, Sensen ^a   Tian, Yonglu ^b   Burton, Casey ^c   Xu, Xinyuan ^a   Liu, Yi ^a   Chang, Cuilan ^a   Bai, Yu ^a   Liu, Huwei ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; FENCLONINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SEROTONIN; SEROTONIN ANTAGONIST; SUPEROXIDE DISMUTASE; TPH2 PROTEIN, MOUSE; TRYPTOPHAN HYDROXYLASE;

ANIMAL; BRAIN; CLUSTER ANALYSIS; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; METABOLISM; METABOLOME; METABOLOMICS; MOUSE; PROCEDURES;

ANIMALS; ANTIOXIDANTS; BIOMARKERS; BRAIN; CLUSTER ANALYSIS; FENCLONINE; GLUTATHIONE PEROXIDASE; MALONDIALDEHYDE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MICE; MICE, KNOCKOUT; REACTIVE OXYGEN SPECIES; SEROTONIN; SEROTONIN ANTAGONISTS; SUPEROXIDE DISMUTASE; TRYPTOPHAN HYDROXYLASE;

EID: 84936885031     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11864     Document Type: Article

References (60)

1. Berger, M., Gray, J. A. & Roth, B. L. The Expanded Biology of Serotonin. Annu. Rev. Med. 60, 355-366 (2009).
2. Kriegebaum, C., Gutknecht, L., Schmitt, A., Lesch, K. P. & Reif, A. Serotonin now: Part 1. Neurobiology and developmental genetics. Fortschr. Neurol. Psychiatr. 78, 319-331 (2010).
3. Kiser, D., SteemerS, B., Branchi, I. & Homberg, J. R. The reciprocal interaction between serotonin and social behaviour. Neurosci. Biobehav. Rev. 36, 786-798 (2012).
4. Nichols, D. E. & Nichols, C. D. Serotonin receptors. Chem. Rev. 108, 1614-1641 (2008).
5. Gershon, M. D. & Tack, J. The serotonin signaling system: From basic understanding to drug development-for functional GI disorders. Gastroenterology 132, 397-414 (2007).
6. Hayes, D. J. & Greenshaw, A. J. 5-HT receptors and reward-related behaviour: A review. Neurosci. Biobehav. Rev. 35, 1419-1449 (2011).
7. Gray, J. A. & Roth, B. L. The pipeline and future of drug development in schizophrenia. Mol. Psychiatr. 12, 904-922 (2007).
8. Rosell, D. R. et al. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol. Psychiatry 67, 1154-1162 (2010).
9. Witte, A. V. et al. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum. Brain Mapp. 30, 2558-2570 (2009).
10. Olivier, B. & van Oorschot, R. 5-HT(1B) receptors and aggression: A review. Eur. J. Pharmacol. 526, 207-217 (2005).
11. Sari, Y. Serotonin(1B) receptors: from protein to physiological function and behavior. Neurosci. Biobehav. Rev. 28, 565-582 (2004).
12. Johnson, C. H. & Gonzalez, F. J. Challenges and opportunities of metabolomics. J. Cell. Physiol. 227, 2975-2981 (2012).
13. Jia, H. M. et al. Integration of H-1 NMR and UPLC-Q-TOF/MS for a comprehensive urinary metabonomics study on a rat model of depression induced by chronic unpredictable mild stress. Plos One 8, e63624 (2013).
14. Yang, J. et al. Potential metabolite markers of schizophrenia. Mol. Psychiatr. 18, 67-78 (2013).
15. Bogdanov, M. et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131, 389-396 (2008).
16. Koe, B. K. & Weissman, A. p-Chlorophenylalanine - a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154, 499-516 (1966).
17. Jequier, E., Lovenber., W. & Sjoerdsm., A. Tryptophan hydroxylase inhibition - mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol. Pharmacol. 3, 274-278 (1967).
18. Higley, J. D. & Linnoila, M. Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior - A nonhuman primate model investigating genetic and environmental influences on neurotransmission. Ann. N.Y. Acad. Sci. 836, 39-56 (1997).
19. Jacobsen, J. P. R., Medvedev, I. O. & Caron, M. G. The 5-HT deficiency theory of depression: Perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2(Arg)439(His) knockin mouse. Philos. Trans. R. Soc. B-Biol. Sci. 367, 2444-2459 (2012).
20. Badawy, A. A. B. Tryptophan: The key to boosting brain serotonin synthesis in depressive illness. J. Psychopharmacol. 27, 878-893 (2013).
21. Rodriguez, J. J., Noristani, H. N. & Verkhratsky, A. The serotonergic system in ageing and Alzheimer's disease. Prog. Neurobiol. 99, 15-41 (2012).
22. Meltzer, C. C. et al. Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging. Neuropsychopharmacology 18, 407-430 (1998).
23. Huot, P. & Fox, S. H. The serotonergic system in motor and non-motor manifestations of Parkinson's disease. Exp. Brain Res. 230, 463-476 (2013).
24. Tan, S. K. H., Hartung, H., Sharp, T. & Temel, Y. Serotonin-dependent depression in Parkinson's disease: A role for the subthalamic nucleus? Neuropharmacology 61, 387-399 (2011).
25. Craven, R. M., Priddle, T. H., Cooper, S. J., Crow, T. J. & Esiri, M. M. The dorsal raphe nucleus in schizophrenia: a post mortem study of 5-hydroxytryptamine neurones. Neuropathol. Appl. Neurobiol. 31, 258-269 (2005).
26. Gutknecht, L., Kriegebaum, C., Waider, J., Schmitt, A. & Lesch, K. P. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol 19, 266-282 (2009).
27. Schwarcz, R. & Pellicciari, R. Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities. J. Pharmacol. Exp. Ther. 303, 1-10 (2002).
28. Schiepers, O. J. G., Wichers, M. C. & Maes, M. Cytokines and major depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29, 201-217 (2005).
29. Takikawa, O. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. Biochem. Biophys. Res. Commun. 338, 12-19 (2005).
30. Capuron, L. et al. Interferon-alpha-induced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment. Biol. Psychiatry 54, 906-914 (2003).
31. Erhardt, S. et al. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci. Lett. 313, 96-98 (2001).
32. Schwarcz, R. et al. Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50, 521-530 (2001).
33. Okuda, S., Nishiyama, N., Saito, H. & Katsuki, H. 3-hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J. Neurochem. 70, 299-307 (1998).
34. Hoekstra, R. et al. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiatry Res. 103, 115-123 (2001).
35. Hashimoto, R. et al. Plasma tetrahydrobiopterin levels in patients with psychiatric disorders. Neuropsychobiology 23, 140-143 (1990).
36. Richardson, M. A., Read, L. L., Reilly, M. A., Clelland, J. D. & Clelland, C. L. T. Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder. Neurochem. Res. 32, 107-113 (2007).
37. Xu, J. et al. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers. Mol. Cell. Proteomics 12, 1306-1318 (2013).
38. Liang, X. P. et al. Pathogenesis of neural tube defects: the story beyond methylation or one-carbon unit metabolism. Metabolomics 8, 919-929 (2012).
39. Lim, Y. A. et al. A beta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 10, 1621-1633 (2010).
40. Tecott, L. H. Serotonin and the orchestration of energy balance. Cell Metab. 6, 352-361 (2007).
41. Tecott, L. H. & Abdallah, L. Mouse genetic approaches to feeding regulation: Serotonin 5-HT2C receptor mutant mice. CNS Spectr. 8, 584-588 (2003).
42. Brunelli, L. et al. A combination of untargeted and targeted metabolomics approaches unveils changes in the kynurenine pathway following cardiopulmonary resuscitation. Metabolomics 9, 839-852 (2013).
43. Yao, J. K. et al. Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naive patients with schizophrenia. Plos One 5, e9508 (2010).
44. Chaudhari, K. et al. Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder. Indian J. Clin. Biochem. 25, 77-81 (2010).
45. Yao, J. K., Reddy, R. & van Kammen, D. P. Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Res. 80, 29-39 (1998).
46. Kim, T. S. et al. Decreased plasma antioxidants in patients with Alzheimer's disease. Int. J. Geriatr. Psychiatr. 21, 344-348 (2006).
47. de Lau, L. M. L., Koudstaal, P. J., Hofman, A. & Breteler, M. M. B. Serum uric acid levels and the risk of Parkinson disease. Ann. Neurol. 58, 797-800 (2005).
48. Ascherio, A. et al. Urate as a predictor of the rate of clinical decline in parkinson disease. Arch. Neurol. 66, 1460-1468 (2009).
49. Sapirstein, A. & Bonventre, J. V. Phospholipases A(2) in ischemic and toxic brain injury. Neurochem. Res. 25, 745-753 (2000).
50. Nicholson, J. K., Holmes, E. & Wilson, I. D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431-438 (2005).
51. Liu, Y. et al. Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice. Nature 472, 95-125 (2011).
52. Kim, J. Y., Kim, A., Zhao, Z. Q., Liu, X. Y. & Chen, Z. F. Postnatal maintenance of the 5-Ht1a-Pet1 autoregulatory loop by serotonin in the raphe nuclei of the brainstem. Mol. Brain 7, 48-58 (2014).
53. Liu, Z. et al. Dorsal raphe neurons signal reward through 5-HT and glutamate. Neuron 81, 1360-1374 (2014).
54. Gika, H. G., Theodoridis, G. A., Wingate, J. E. & Wilson, I. D. Within-day reproducibility of an HPLC-MS-Based method for metabonomic analysis: Application to human urine. J. Proteome Res. 6, 3291-3303 (2007).
55. Nugent, J. L. et al. Altered Tissue Metabolites Correlate with Microbial Dysbiosis in Colorectal Adenomas. J. Proteome Res. 13, 1921-1929 (2014).
56. Want, E. J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nature 5, 1005-1018 (2010).
57. Bijlsma, S. et al. Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation. Anal. Chem. 78, 567-574 (2006).
58. Xia, J. G., Mandal, R., Sinelnikov, I. V., Broadhurst, D. & Wishart, D. S. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40, W127-W133 (2012).
59. Xia, J. G. & Wishart, D. S. MetPA: A web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 26, 2342-2344 (2010).
60. Bradford, M. M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).